These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34679518)

  • 1. Differences in Hemodynamic Alteration between Atherosclerotic Occlusive Lesions and Moyamoya Disease: A Quantitative
    Igarashi C; Okazawa H; Islam MM; Tsujikawa T; Higashino T; Isozaki M; Kikuta KI
    Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of cerebrovascular reserve in acetazolamide challenge -comparison with acetazolamide challenge H2O-PET and Gas-PET.
    Imaizumi M; Kitagawa K; Oku N; Hashikawa K; Takasawa M; Yoshikawa T; Osaki Y; Matsushita K; Matsumoto M; Hori M; Hatazawa J
    Ann Nucl Med; 2004 Jul; 18(5):369-74. PubMed ID: 15462398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal timing for measuring cerebral blood flow after acetazolamide administration to detect preexisting cerebral hemodynamics and metabolism in patients with bilateral major cerebral artery steno-occlusive diseases:
    Kobayashi M; Igarashi S; Takahashi T; Fujiwara S; Chida K; Terasaki K; Kubo Y; Ogasawara K
    Am J Nucl Med Mol Imaging; 2021; 11(6):507-518. PubMed ID: 35003888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral hemodynamics and metabolism in adult moyamoya disease: comparison of angiographic collateral circulation.
    Piao R; Oku N; Kitagawa K; Imaizumi M; Matsushita K; Yoshikawa T; Takasawa M; Osaki Y; Kimura Y; Kajimoto K; Hori M; Hatazawa J
    Ann Nucl Med; 2004 Apr; 18(2):115-21. PubMed ID: 15195758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity?
    Okazawa H; Tsuchida T; Kobayashi M; Arai Y; Pagani M; Isozaki M; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):121-9. PubMed ID: 16896662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
    Okazawa H; Yamauchi H; Sugimoto K; Takahashi M
    J Nucl Med; 2003 Sep; 44(9):1371-8. PubMed ID: 12960179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical reduction of cerebral blood flow after acetazolamide loading: a hemodynamic and metabolic study with (15)O PET.
    Watabe T; Shimosegawa E; Kato H; Isohashi K; Ishibashi M; Tatsumi M; Kitagawa K; Fujinaka T; Yoshimine T; Hatazawa J
    Neurosci Bull; 2014 Oct; 30(5):845-56. PubMed ID: 25096497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implication and prognosis of normal baseline cerebral blood flow with impaired vascular reserve in patients with major cerebral artery occlusive disease.
    Isozaki M; Arai Y; Kudo T; Kiyono Y; Kobayashi M; Kubota T; Kikuta K; Okazawa H
    Ann Nucl Med; 2010 Jun; 24(5):371-7. PubMed ID: 20238185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases.
    Kuroda S; Shiga T; Ishikawa T; Houkin K; Narita T; Katoh C; Tamaki N; Iwasaki Y
    J Nucl Med; 2004 Jun; 45(6):943-9. PubMed ID: 15181128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posthyperventilatory steal response in chronic cerebral hemodynamic stress: a positron emission tomography study.
    Nariai T; Senda M; Ishii K; Wakabayashi S; Yokota T; Toyama H; Matsushima Y; Hirakawa K
    Stroke; 1998 Jul; 29(7):1281-92. PubMed ID: 9660374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease.
    Chen A; Shyr MH; Chen TY; Lai HY; Lin CC; Yen PS
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1876-81. PubMed ID: 17032859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
    Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamide and cerebral blood flow SPECT imaging.
    Kuroda H; Ogasawara K; Suzuki T; Chida K; Aso K; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Kubo Y; Ogawa A
    Clin Nucl Med; 2012 Mar; 37(3):235-40. PubMed ID: 22310248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Fukumura T; Masuda K; Fujii K; Fukui M
    J Nucl Med; 1998 May; 39(5):760-5. PubMed ID: 9591570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral hemodynamics and oxygen metabolism in patients with moyamoya syndrome associated with atherosclerotic steno-occlusive arterial lesions.
    Kato H; Shimosegawa E; Oku N; Kimura Y; Kajimoto K; Tanaka M; Hori M; Kitagawa K; Hatazawa J
    Cerebrovasc Dis; 2008; 26(1):9-15. PubMed ID: 18511866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetazolamide-Loaded Dynamic 7T MR Quantitative Susceptibility Mapping in Major Cerebral Artery Steno-Occlusive Disease: Comparison with PET.
    Fujimoto K; Uwano I; Sasaki M; Oshida S; Tsutsui S; Yanagihara W; Fujiwara S; Kobayashi M; Kubo Y; Yoshida K; Terasaki K; Ogasawara K
    AJNR Am J Neuroradiol; 2020 May; 41(5):785-791. PubMed ID: 32299799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between cerebral circulatory reserve and oxygen extraction fraction in patients with major cerebral artery occlusive disease: a positron emission tomography study.
    Yata K; Suzuki A; Hatazawa J; Shimosegawa E; Nagata K; Sato M; Moroi J
    Stroke; 2006 Feb; 37(2):534-6. PubMed ID: 16410481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging Hemodynamic Failure With Blood Oxygen-Level-Dependent Functional Magnetic Resonance Imaging Cerebrovascular Reactivity: A Comparison Versus Gold Standard (
    Fierstra J; van Niftrik C; Warnock G; Wegener S; Piccirelli M; Pangalu A; Esposito G; Valavanis A; Buck A; Luft A; Bozinov O; Regli L
    Stroke; 2018 Mar; 49(3):621-629. PubMed ID: 29371433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Arterial Transit Time and Cerebrovascular Reactivity in Moyamoya Disease by Simultaneous PET/MRI.
    Takata K; Kimura H; Ishida S; Isozaki M; Higashino Y; Kikuta KI; Okazawa H; Tsujikawa T
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.